Table 1 Inclusion and exclusion criteria for controls and end-stage renal disease (ESRD) patients on hemodialysis (HD) treatment.

From: Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis

 

Control

ESRD on HD

Enrolment criteria

Age, years

 > 18

 > 18

Time on dialysis treatment

 > 3 months

Enrolled participants, n

44

308

Excluded participants, n

High cholesterol

1

Arterial hypertension

6

Antiphospholipid syndrome

1

Prediabetes

1

Under chronic drug treatment

3

Active infection

14

Neoplasia

5

Included participants, n

32

289

Participants excluded during the follow-up period, n

Kidney transplant

14

Renal function recovery

2

Clinic transfer

3

Dialysis abandonment

2

Participants included in the 1-year follow-up study, n

268